Kenneth Gordon to Safety Management
This is a "connection" page, showing publications Kenneth Gordon has written about Safety Management.
Connection Strength
0.100
-
Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): results from analyses of infections and malignancy from pooled phase II and III clinical trials. J Am Acad Dermatol. 2012 May; 66(5):742-51.
Score: 0.100